Bloom Technology is a research-oriented biotechnology company, with a focus on advanced glycation end-products (AGEs), founded with support from academia, and is committed to developing highly innovative therapeutics for AGE-related diseases. AGEs, which are produced from so-called Maillard reaction between proteins and glucose, have been reported to accelerate aging as well as multiple diseases. Age spots and wrinkles, for example, are associated with AGEs, and therefore, reducing AGEs possibly has an anti-aging effect, which is gaining increasing interests particularly in the field of cosmetics.

  Among various AGEs reported so far, toxic AGEs (TAGEs) have been implicated in the pathogenesis of various diseases such as cardiovascular diseases, Alzheimer’s disease, NASH, cancer, and infertility. As TAGEs are likely to play vital roles in human health and diseases, anti-TAGE therapies to suppress TAGEs are becoming more important and promising, on which we are currently focusing our efforts.

  In view of growing biology of AGE-related diseases, we are developing antibodies for targeting TAGEs. To help people enjoy a healthier and better life with our antibody technologies is our strong wish and goal.